Formation Bio Platform
AI-powered clinical trial acceleration platform
Platform · Cloud SaaSCompany source
Company profile
About Formation Bio
Formation Bio is a technology-driven pharmaceutical company that combines drug development with advanced AI and software solutions to transform the clinical trial process. The company operates on a dual mission: developing its own pipeline of therapeutic candidates while building proprietary technology platforms that accelerate drug development timelines and reduce costs. Formation Bio's approach integrates data science, machine learning, and clinical operations expertise to address inefficiencies in traditional pharmaceutical development. The company's technology platform aims to streamline patient recruitment, trial design, data collection, and regulatory processes. By leveraging real-world data and predictive analytics, Formation Bio seeks to make clinical trials faster, more efficient, and more likely to succeed. The company serves both its internal drug development programs and partners with other pharmaceutical and biotech companies looking to modernize their clinical development operations.
Company description Formation Bio official website
Primary marketClinical Trials & Research
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Formation Bio?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
No clinical focus areas are currently listed.
Who it serves
- Biotech
- Pharma
Deployment & integration
Cloud Saas deployment with recorded integration context.
Geographic context
MarketsNot currently listed
Company sourceOfficial website
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
TRAIL splice variant TRAILshort disrupts T cell receptor signaling and promotes immune tolerance in vivo.The Journal of clinical investigation · Aug 3, 2026
New onset seizure etiologies and outcomes among adults with HIV in the era of broadly available antiretroviral therapies.Seizure · Apr 1, 2026
Exploring a novel outcome measure of symptom progression in knee osteoarthritis utilizing a large randomized trial.Osteoarthritis and cartilage · Mar 1, 2025
Unbiased analysis of knee cartilage thickness change over three years after sprifermin vs. placebo treatment - A post-hoc analysis from the phase 2B FORWARD study.Osteoarthritis and cartilage open · Dec 1, 2024
Is detection of disease-modifying osteoarthritis drug treatment more effective when performing cartilage morphometry without blinding to MR image acquisition order?Osteoarthritis and cartilage · Oct 1, 2024
Clinical validation
Clinical-trial records
A Phase 1 Study of BLKR201 in Healthy Adult ParticipantsNCT07501039 · Sponsor · RECRUITING
A Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic DermatitisNCT05870865 · Sponsor · COMPLETED
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Formation Bio
Recent articles published on Formation Bio's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Clinical Trials & Research
Companies using AI to optimize clinical trial design, accelerate patient recruitment, match patients to trials, predict trial outcomes, or improve clinical research efficiency. Includes patient enrollment and screening platforms, AI-powered trial matching, and tools that reduce the time and cost of bringing new treatments to market.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.